T1	Procedure 25 34	Treatment
E1	Procedure:T1
T2	Modifier 35 40	na√Øve
E2	Modifier:T2
T3	Or 41 43	or
E3	Or:T3
T4	Condition 46 52	pegIFN
E4	Condition:T4
T5	Or 54 56	or
E5	Or:T5
T6	Condition 57 60	IFN
E6	Condition:T6 Name:T33
T7	Or 63 69	and/or
E7	Or:T7
T8	Drug 70 79	Ribavirin
E8	Drug:T8 Name:T34
T9	Drug 81 84	RBV
E9	Drug:T9 Name:T35
T10	Or 86 92	and/or
E10	Or:T10
T11	Drug 93 103	sofosbuvir
E11	Drug:T11 Name:T36
T12	Condition 105 108	PRS
E12	Condition:T12 Name:T37
T13	Condition 137 140	CHC
E13	Condition:T13 Name:T38
T14	Condition 142 151	genotypes
E14	Condition:T14
T15	Eq-Comparison 158 171	3, 4, 5, or 6
E15	Eq-Comparison:T15 Value:T40 Value:T41 Value:T42 Value:T43
T16	And 173 177	with
E16	And:T16
T17	Or 178 180	or
E17	Or:T17
T18	Modifier 181 200	without compensated
E18	Modifier:T18
T19	Condition 201 210	cirrhosis
E19	Condition:T19 Name:T44
T20	Eq-Comparison 212 221	receiving
E20	Eq-Comparison:T20 Temporal-Period:T45
T21	Procedure 222 241	combination therapy
E21	Procedure:T21 Name:T46
T22	Procedure 255 263	oral GLE
E22	Procedure:T22
T23	Or 263 264	/
E23	Or:T23
T24	Drug 264 267	PIB
E24	Drug:T24 Name:T48
T25	Eq-Comparison 395 408	up to 4 weeks
E25	Eq-Comparison:T25 Operator:T50 Value:T51 Temporal-Unit:T52
T26	Temporal-Connection 409 414	after
E26	Temporal-Connection:T26
A1	Temporal-Connection-Type-Value E26 after
T27	Procedure 415 424	treatment
E27	Procedure:T27
T28	Eq-Comparison 425 435	initiation
E28	Eq-Comparison:T28
T29	Temporal-Connection 504 509	prior
E29	Temporal-Connection:T29
A2	Temporal-Connection-Type-Value E29 before
T30	Study 532 537	study
E30	Study:T30
T31	Negation 557 560	not
E31	Negation:T31
T32	Procedure 637 654	therapeutic trial
E32	Procedure:T32
T33	Condition-Name 57 60	IFN
T34	Drug-Name 70 79	Ribavirin
T35	Drug-Name 81 84	RBV
T36	Drug-Name 93 103	sofosbuvir
T37	Condition-Name 105 108	PRS
T38	Condition-Name 137 140	CHC
T39	Eq-Value 155 156	2
T40	Eq-Value 158 159	3
T41	Eq-Value 161 162	4
T42	Eq-Value 164 165	5
T43	Eq-Value 170 171	6
T44	Condition-Name 201 210	cirrhosis
T45	Eq-Temporal-Period 212 221	receiving
A3	Eq-Temporal-Period-Value T45 present
T46	Procedure-Name 222 241	combination therapy
T47	Drug-Name 255 263	oral GLE
T48	Drug-Name 264 267	PIB
T49	Eq-Temporal-Period 353 360	current
A4	Eq-Temporal-Period-Value T49 present
T50	Eq-Operator 398 400	to
A5	Eq-Operator-Value T50 BETWEEN
T51	Eq-Value 401 402	4
T52	Eq-Temporal-Unit 403 408	weeks
A6	Eq-Temporal-Unit-Value T52 week